Physician profile
Benjamin Allen Root, JR.
NPI 1275671000
$1,733.02
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,123 · 2020: $598 · 2021: $11.78.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $328.83 | 2019-2020 | |
| Allergan, INC. | $315.60 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $255.63 | 2019-2020 | |
| Lundbeck LLC | $198.69 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $176.03 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $119.10 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $75.67 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $74.64 | 2019-2020 | |
| Eisai INC. | $57.44 | 2020 | |
| Shire North American Group INC | $30.50 | 2019 | |
| Arbor Pharmaceuticals, INC. | $26.41 | 2019 | |
| Alfasigma USA, INC. | $22.84 | 2020 | |
| Neurocrine Biosciences, INC. | $14.46 | 2019 | |
| Adlon Therapeutics L.P. | $13.99 | 2020 | |
| Abbvie INC. | $11.78 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.41 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Root listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.